It is of interest that dietary factors affect de novo hepatic lipogenesis via the crucial factors FASN and PPARγ, and can thereby mitigate NAFLD and obesity, based on a cell and an animal model [6, 7]. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.